Evolution News and Research

RSS

FDA clears multiple enhancements to St. Jude Medical's FFR measurement guidewire

St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR) measurement guidewire.

23 Mar 2012

Advances in Neuroimmune Biology explores maternal-fetal interactions

Fertility problems, recurrent miscarriages, and pregnancy complications can occur when maternal immunological tolerance of the fetus is impaired. G-rard Chaouat and colleagues from Inserm et Assistance Publique et Universit- Paris Sud Orsay, Hopital Antoine B-cl-re, Clamart Cedex, France, trace the evolution of the science of reproductive immunology to show how the current understanding of maternal-fetal tolerance/dialogue has developed, and its implications for the treatment of infertility disorders

22 Mar 2012

WESTMED collaborates with UnitedHealthcare to launch ACO

WESTMED Medical Group announced it is collaborating with the UnitedHealthcare and Optum businesses of UnitedHealth Group to launch an accountable care organization (ACO) for its more than 220 physicians in Westchester County, N.Y.

21 Mar 2012

New perspective on why the immune system makes us worse while trying to make us well

A new article in The Quarterly Review of Biology helps explain why the immune system often makes us worse while trying to make us well.

21 Mar 2012

RaySearch receives PMH contract for new adaptive radiation therapy solution

RaySearch Laboratories AB has been awarded a contract for a new adaptive radiation therapy solution at Princess Margaret Hospital (PMH) in Toronto, Canada. This means that RaySearch will deliver its treatment planning system RayStation to PMH where it will be used as the primary treatment planning tool for adaptive radiation therapy.

20 Mar 2012

Tyler Prize for Environmental Achievement honors two experts on air pollution

Tyler Prize for Environmental Achievement honors two experts on air pollution with the 2012 Tyler Prize for their work to advance the scientific understanding of air pollution, and develop solutions to reduce the danger to human health and the impact on climate change.

20 Mar 2012

Tobii completes USD $21 million funding round

Tobii Technology, the global leader in eye tracking and gaze interaction, announced today that it has closed a USD $21M funding round. New investor Intel Capital joins existing investors Amadeus Capital, Investor Growth Capital and Northzone Ventures.

20 Mar 2012

Study identifies new hypervariable regions in human gut viruses

A growing body of evidence underscores the importance of human gut bacteria in modulating human health, metabolism, and disease. Yet bacteria are only part of the story. Viruses that infect those bacteria also shape who we are. Frederic D. Bushman, PhD, professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, led a study published this month in the Proceedings of the National Academy of Sciences that sequenced the DNA of viruses -- the virome -- present in the gut of healthy people.

20 Mar 2012

Medicare plan will be central to Ryan GOP budget

House Budget Committee Chairman Paul Ryan, R-Wis., is set to unveil a new budget plan on Tuesday. Both Democrats and Republicans are poised to revive the pitched debate over controversial proposals related to the Medicare programs.

19 Mar 2012

First Edition: March 19, 2012

Today's headlines reflect the anticipation and anxiety that surrounds the Supreme Court's upcoming health law oral arguments.

19 Mar 2012

arGEN-X introduces NHance technology to create therapeutic antibodies

arGEN-X announces today the launch of NHance, its latest cutting-edge technology enabling the creation of truly differentiated human antibody therapeutics.

19 Mar 2012

Study reveals why development of HIV treatments has been difficult

A new research report appearing in the March 2012 issue of the journal Genetics shows why the development of a cure and new treatments for HIV has been so difficult. In the report, an Australian scientist explains how he used computer simulations to discover that a population starting from a single human immunodeficiency virus can evolve fast enough to escape immune defenses.

16 Mar 2012

Epigenetic designer baby may prove to be a non-starter

Epigenetics is the new hip science. Time Magazine's front cover and article, 'Why your DNA isn't your Destiny' from January 2010 explains why. Its more explicit subtitle provided the hook - 'The new science of epigenetics reveals how the choices you make can change your genes - and those of your kids'. Who wouldn't be interested in this?

16 Mar 2012

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

16 Mar 2012

Targeted drugs should be aimed at mutations that develop early in blood cancer

The diagnosis of myelodysplastic syndrome, a blood cancer, often causes confusion. While some patients can be treated with repeated blood transfusions, others require chemotherapy, leaving some uncertainty about whether the syndromes actually are cancer.

15 Mar 2012

Chlamydia has evolved more actively than previously thought

In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought. Using whole genome sequencing the researchers show that the exchange of DNA between different strains of Chlamydia to form new strains is much more common than expected.

12 Mar 2012

South Africa's evolving HIV/AIDS policy

In this interview in World Politics Review's "Trend Lines," Peter Navario, an adjunct associate professor of public policy at New York University and a former global health fellow at the Council on Foreign Relations, discusses the evolution South Africa's HIV/AIDS policy over the last decade, the country's current relationship with pharmaceutical companies, and how South African President Jacob Zuma's HIV/AIDS policy is received in the region and by international donors.

10 Mar 2012

New vaccination strategy may effectively eradicate HIV-1 infection

In what may prove to be a major step forward for the treatment of HIV-1 infection, scientists have discovered an effective way to eliminate a notoriously persistent form of the virus that does not respond to current therapies. The research, published online by Cell Press on March 8th from the journal Immunity, describes a vaccination strategy that may be essential for successful eradication efforts and should therefore be considered for future clinical trials.

9 Mar 2012

Maxygen reports net loss of $2.2 million for fourth quarter 2011

Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.

9 Mar 2012

Do we age as a consequence of being protected against cancer?

The role of one of our genes which protects us from cancer but could also cause us to age will be explained in a lecture at the University of Leicester.

8 Mar 2012